Related Experiment Video
Updated: May 13, 2026
04:03
Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
Published on: March 28, 2025
Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: A
Yangyang Liu1, Peizhu Su, Yinghao Lin
1Institute of Digestive Diseases, Nanfang Hospital, Guangzhou, China.
Journal of Gastroenterology and Hepatology
|March 16, 2013
Summary
Endoscopic balloon dilation combined with sphincterotomy (ESBD) is a safe and effective treatment for bile duct stones, showing comparable stone removal rates to endoscopic sphincterotomy (EST) alone. ESBD resulted in less bleeding and fewer complications, particularly for larger stones.
Area of Science:
- Gastroenterology
- Endoscopic procedures
- Biliary tract interventions
Background:
- Endoscopic sphincterotomy (EST) and EST combined with balloon dilation (ESBD) are key endoscopic techniques for bile duct stone extraction.
- Comparing the efficacy and safety of these two methods is crucial for clinical decision-making.
Purpose of the Study:
- To conduct a meta-analysis comparing the efficacy and safety of ESBD versus EST for bile duct stone removal.
- To evaluate outcomes such as stone removal success, need for mechanical lithotripsy, complications, and post-procedure pancreatitis.
Main Methods:
- Meta-analysis of randomized controlled trials (RCTs) and nonrandomized studies.
- Comparison of stone removal in the first session, need for endoscopic mechanical lithotripsy (EML), overall complications, and post-ERCP pancreatitis.
Main Results:
- RCTs indicated equivalent stone removal and EML utility between ESBD and EST.
- ESBD showed equivalent complications and post-ERCP pancreatitis but significantly less bleeding.
- Retrospective studies revealed higher initial stone removal success and less EML with ESBD, along with fewer overall complications.
- For stones ≥ 15 mm, ESBD required less EML and caused fewer complications.
Conclusions:
- ESBD is a feasible treatment for choledocholithiasis, offering reduced bleeding and no increased risk of complications compared to EST.
- Further clinical trials are needed to definitively compare the efficacy and safety profiles of ESBD and EST.
